ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.

Omega Funds

F-Prime Capital

Third Rock Ventures

ARTBIO

We are #hiring across a variety of roles in CMC, Quality and Clinical to bring our #alpha #radioligand #therapies to patients. 

Check out ARTBIO's open positions and feel free to get in touch.

https://lnkd.in/eKK7vxdz 

Daniel Rossetto Jordi Vall-llossera ✪ Philippe Dasse ✪ ☤ Emanuele Ostuni

Thank you Richard Zimmermann for including ARTBIO in this helpful overview recently published in The Journal of Nuclear Medicine - JNM. 

This editorial discusses the potential of #Pb212 as an ideal #isotope for #alpha #radioligand #therapy based on its ability to overcome challenges seen with other isotopes in the #radiopharmaceutical space. Its many ideal properties include precursor supply, a short half-life, a high energy deposition into tumors and a potentially lower environmental footprint. 

Learn more about how we are leveraging Pb212 in our approach: https://lnkd.in/emDFdbTY 
 
 #nuclearmedicine #biotech

Such a privilege for ARTBIO to present our vision for leveraging AlphaDirect and 212-Pb as a potential game changer in radioligand therapy at JPM24!  2024 is going to be a really exciting year for us; especially the clinical advancement of our lead PSMA asset, AB001. Extremely proud of Emanuele Ostuni, the ARTBIO team, the ingenuity of our founders and tenacity our dedicated investors to support our mission to be the Leader in Lead!

#JPMHC24 #radiopharmaceuticals

Endocyte is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and other serious diseases.

Endocyte

Bayer AG is a multinational pharmaceutical and life sciences company that develops and markets innovative products for the healthcare industry.

Bayer AG

Novartis AG is a global healthcare company that provides solutions to address the evolving needs of patients worldwide.

Novartis AG

ARTBIO is a company focused on radioligand therapy (RLT) for cancer treatment. Their approach is patient-centric and holistic, with a deep understanding of cancer biology and the infrastructure for therapy design, manufacture, and distribution.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 16, 2024 2:26 AM	66719a65
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	bce7a3bf
crunchbase profile	general
li profile	general	Feb 16, 2024 2:26 AM	01e554fd
translate crunchbase fundingrounds	general
peers	general	Feb 16, 2024 2:26 AM	cb0deeed
news basic	general	Feb 16, 2024 2:26 AM	86858c98
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ARTBIO

ARTBIO